Alexandria Real Estate Equities has seen its share price fall sharply over the past few years, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both suggest the stock may now be trading at a discount to its underlying cash flow potential.

• Over the last 5 years, Alexandria Real Estate Equities has declined about 70%, which puts recent sentiment and current pricing under clear pressure.
• Progress on initiatives such as the precision medicine partnership for depression care can support confidence in future cash flow generation, while any setbacks in executing its life sciences focused property strategy may weigh on how much of that potential investors are willing to pay for today.
• On Simply Wall St's broader checks, Alexandria Real Estate Equities screens as undervalued in 5 of 6 valuation tests, which points to a share price that looks cheap against several fundamental yardsticks.

The issue now is whether that apparent discount, including the DCF estimate that implies roughly 22.9% upside to intrinsic value, offers enough compensation for the risks around Alexandria Real Estate Equities' long term cash flows.

Does Alexandria Real Estate Equities Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) model here is based on adjusted funds from operations and aims to link Alexandria Real Estate Equities' current price to its projected cash generation.

On the latest twelve month numbers, Alexandria Real Estate Equities generated about $1.53b in free cash flow. The model assumes cash flows that broadly grow from current levels and uses these projections to arrive at an estimated intrinsic value of about $62.85 per share. Compared to the current market price, this suggests the stock trades at roughly a 22.9% discount to this cash flow based estimate.

The recent precision medicine milestone for depression care provides a concrete example of how Alexandria Real Estate Equities is trying to reinforce its life sciences footprint. However, the DCF outcome suggests investors are still pricing the stock below what these cash flows support.

On this DCF view, Alexandria Real Estate Equities appears undervalued relative to its estimated intrinsic value.

Our Discounted Cash Flow (DCF) analysis suggests Alexandria Real Estate Equities is undervalued by 22.9%. Track this in your watchlist or portfolio, or discover 50 more high quality undervalued stocks.

Is Alexandria Real Estate Equities Still Cheap on Sales?

P/S is a useful cross check for Alexandria Real Estate Equities because you are paying for a portfolio of properties that is designed to convert rent into long term cash flows, so revenue is a clean starting point.

Alexandria Real Estate Equities currently trades on a P/S of about 3.0x. That stands well below the Health Care REITs industry average of roughly 6.7x and also below a peer group average of about 6.3x. On Simply Wall St’s fair multiple estimate, which sits at about 4.6x based on factors such as size, margins and risk, the current P/S is still lower.

This implies the market values each dollar of Alexandria Real Estate Equities' sales at a discount to what both peers and the tailored fair multiple suggest. For investors who are comfortable with the company’s life sciences focus and execution risks, that gap may indicate a way to gain exposure to its revenue base at a relatively low price.

On the P/S lens, Alexandria Real Estate Equities stock appears undervalued compared with both sector norms and its own fair multiple.

The Alexandria Real Estate Equities Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the valuation puzzle for Alexandria Real Estate Equities' leaves off and explain which future paths for growth, margins and earnings would make the current share price appear high or low. Each Narrative links a fair value estimate to a specific story about Alexandria Real Estate Equities' potential catalysts and key risks, so you can track over time which version of events seems to be unfolding on the Community page.

Community views on Alexandria Real Estate Equities sit far apart, with one side focused on the discount to assets and the other on pressure from softer demand and costs.

Bull case: 45% undervalued

"After adjustments (e.g., 10% lower NAV), intrinsic value remains well above the current share price, for example a NAV estimate of $98 with a 20% margin of safety yields an intrinsic value around $78..."

Bear case: 15% overvalued

"Sustained high interest rates and restricted access to affordable credit are raising Alexandria's cost of capital at the same time as the company maintains significant capital expenditure needs for maintaining and modernizing highly specialized assets..."

Do you think there's more to the story for Alexandria Real Estate Equities? Head over to our Community to see what others are saying!

The Bottom Line

Alexandria Real Estate Equities screens as undervalued on both the Discounted Cash Flow (DCF) intrinsic value estimate and the P/S comparison with peers, which is a rare alignment for value signals. The key question is whether the discount reflects temporary caution or a lasting concern about the durability of its life sciences focused cash flows. Everything now turns on execution, especially the ability to keep high quality tenants, manage capital spending on specialized assets, and sustain predictable cash generation. The gap between intrinsic value and market price only becomes attractive if you believe those cash flows will remain resilient rather than turning this into a value trap.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.